Global Neurogenetic Testing Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Neurogenetic Testing market size will reach 710.16 Million USD in 2025 and is projected to reach 1,454.07 Million USD by 2032, with a CAGR of 10.78% (2025-2032). Notably, the China Neurogenetic Testing market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Neurogenetic testing refers to a specialized type of genetic testing that focuses on evaluating an individual’s genetic makeup specifically related to neurological conditions and diseases. It involves analyzing genetic variations, mutations, or abnormalities that may be associated with neurological disorders, such as Alzheimer’s disease, Parkinson’s disease, epilepsy, or hereditary neuropathies. Neurogenetic testing typically involves extracting DNA from a patient’s blood or saliva sample, followed by sequencing and analyzing specific genes or regions of the genome relevant to neurological conditions. The results of neurogenetic testing can provide valuable insights into the underlying genetic factors contributing to a person’s neurological symptoms or predisposition to certain disorders, helping with diagnosis, treatment decisions, and the assessment of disease risk for individuals and their families. Additionally, neurogenetic testing plays a significant role in advancing our understanding of the genetic basis of neurological diseases and in the development of personalized therapies in the field of neurology.
The major global suppliers of Neurogenetic Testing include Quest Diagnostics, Mayo Clinic, GeneDx, Illumina, Labcorp, Invitae, Connecticut Children’s, MedGenome Labs, CENTOGENE, Victorian Clinical Genetics Services, PacBio, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Neurogenetic Testing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Neurogenetic Testing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Neurogenetic Testing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Neurogenetic Testing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Neurogenetic Testing Include:
Quest Diagnostics
Mayo Clinic
GeneDx
Illumina
Labcorp
Invitae
Connecticut Children’s
MedGenome Labs
CENTOGENE
Victorian Clinical Genetics Services
PacBio
Neurogenetic Testing Product Segment Include:
Exome Sequencing
Whole Genome Sequencing
RNA Sequencing
General DNA Testing
Neurogenetic Testing Product Application Include:
Hospitals
Specialty Clinics
Research Institutes
Diagnostics Laboratories
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Neurogenetic Testing Industry PESTEL Analysis
Chapter 3: Global Neurogenetic Testing Industry Porter's Five Forces Analysis
Chapter 4: Global Neurogenetic Testing Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Neurogenetic Testing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Neurogenetic Testing Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Neurogenetic Testing Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Neurogenetic Testing market size will reach 710.16 Million USD in 2025 and is projected to reach 1,454.07 Million USD by 2032, with a CAGR of 10.78% (2025-2032). Notably, the China Neurogenetic Testing market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Neurogenetic testing refers to a specialized type of genetic testing that focuses on evaluating an individual’s genetic makeup specifically related to neurological conditions and diseases. It involves analyzing genetic variations, mutations, or abnormalities that may be associated with neurological disorders, such as Alzheimer’s disease, Parkinson’s disease, epilepsy, or hereditary neuropathies. Neurogenetic testing typically involves extracting DNA from a patient’s blood or saliva sample, followed by sequencing and analyzing specific genes or regions of the genome relevant to neurological conditions. The results of neurogenetic testing can provide valuable insights into the underlying genetic factors contributing to a person’s neurological symptoms or predisposition to certain disorders, helping with diagnosis, treatment decisions, and the assessment of disease risk for individuals and their families. Additionally, neurogenetic testing plays a significant role in advancing our understanding of the genetic basis of neurological diseases and in the development of personalized therapies in the field of neurology.
The major global suppliers of Neurogenetic Testing include Quest Diagnostics, Mayo Clinic, GeneDx, Illumina, Labcorp, Invitae, Connecticut Children’s, MedGenome Labs, CENTOGENE, Victorian Clinical Genetics Services, PacBio, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Neurogenetic Testing. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Neurogenetic Testing market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Neurogenetic Testing market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Neurogenetic Testing industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Neurogenetic Testing Include:
Quest Diagnostics
Mayo Clinic
GeneDx
Illumina
Labcorp
Invitae
Connecticut Children’s
MedGenome Labs
CENTOGENE
Victorian Clinical Genetics Services
PacBio
Neurogenetic Testing Product Segment Include:
Exome Sequencing
Whole Genome Sequencing
RNA Sequencing
General DNA Testing
Neurogenetic Testing Product Application Include:
Hospitals
Specialty Clinics
Research Institutes
Diagnostics Laboratories
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Neurogenetic Testing Industry PESTEL Analysis
Chapter 3: Global Neurogenetic Testing Industry Porter's Five Forces Analysis
Chapter 4: Global Neurogenetic Testing Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Neurogenetic Testing Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Neurogenetic Testing Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Neurogenetic Testing Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Neurogenetic Testing Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Neurogenetic Testing Product by Type
- 1.2.1 Exome Sequencing
- 1.2.2 Whole Genome Sequencing
- 1.2.3 RNA Sequencing
- 1.2.4 General DNA Testing
- 1.3 Neurogenetic Testing Product by Application
- 1.3.1 Hospitals
- 1.3.2 Specialty Clinics
- 1.3.3 Research Institutes
- 1.3.4 Diagnostics Laboratories
- 1.4 Global Neurogenetic Testing Market Size Analysis (2020-2032)
- 1.5 Neurogenetic Testing Market Development Status and Trends
- 1.5.1 Neurogenetic Testing Industry Development Status Analysis
- 1.5.2 Neurogenetic Testing Industry Development Trends Analysis
- 2 Neurogenetic Testing Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Neurogenetic Testing Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Neurogenetic Testing Market Analysis by Country
- 4.1 Global Neurogenetic Testing Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Neurogenetic Testing Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Neurogenetic Testing Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Neurogenetic Testing Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Neurogenetic Testing Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Neurogenetic Testing Market Revenue and Growth Rate (2020-2032)
- 4.5 China Neurogenetic Testing Market Revenue and Growth Rate (2020-2032)
- 4.6 France Neurogenetic Testing Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Neurogenetic Testing Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Neurogenetic Testing Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Neurogenetic Testing Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Neurogenetic Testing Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Neurogenetic Testing Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Neurogenetic Testing Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Neurogenetic Testing Market Revenue and Growth Rate (2020-2032)
- 4.14 India Neurogenetic Testing Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Neurogenetic Testing Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Neurogenetic Testing Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Neurogenetic Testing Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Neurogenetic Testing Market Revenue by Key Suppliers (2021-2025)
- 5.2 Neurogenetic Testing Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Neurogenetic Testing Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Neurogenetic Testing Market Analysis by Type
- 6.1 Global Neurogenetic Testing Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Neurogenetic Testing Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Quest Diagnostics
- 7.1.1 Quest Diagnostics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Quest Diagnostics Neurogenetic Testing Product Portfolio
- 7.1.3 Quest Diagnostics Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Mayo Clinic
- 7.2.1 Mayo Clinic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Mayo Clinic Neurogenetic Testing Product Portfolio
- 7.2.3 Mayo Clinic Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 GeneDx
- 7.3.1 GeneDx Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 GeneDx Neurogenetic Testing Product Portfolio
- 7.3.3 GeneDx Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Illumina
- 7.4.1 Illumina Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Illumina Neurogenetic Testing Product Portfolio
- 7.4.3 Illumina Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Labcorp
- 7.5.1 Labcorp Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Labcorp Neurogenetic Testing Product Portfolio
- 7.5.3 Labcorp Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Invitae
- 7.6.1 Invitae Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Invitae Neurogenetic Testing Product Portfolio
- 7.6.3 Invitae Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Connecticut Children’s
- 7.7.1 Connecticut Children’s Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Connecticut Children’s Neurogenetic Testing Product Portfolio
- 7.7.3 Connecticut Children’s Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 MedGenome Labs
- 7.8.1 MedGenome Labs Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 MedGenome Labs Neurogenetic Testing Product Portfolio
- 7.8.3 MedGenome Labs Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 CENTOGENE
- 7.9.1 CENTOGENE Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 CENTOGENE Neurogenetic Testing Product Portfolio
- 7.9.3 CENTOGENE Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Victorian Clinical Genetics Services
- 7.10.1 Victorian Clinical Genetics Services Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Victorian Clinical Genetics Services Neurogenetic Testing Product Portfolio
- 7.10.3 Victorian Clinical Genetics Services Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 PacBio
- 7.11.1 PacBio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 PacBio Neurogenetic Testing Product Portfolio
- 7.11.3 PacBio Neurogenetic Testing Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Neurogenetic Testing Industry Chain Analysis
- 8.2 Neurogenetic Testing Product Downstream Application Analysis
- 8.2.1 Global Neurogenetic Testing Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Neurogenetic Testing Revenue and Forecast by Application (2020-2032)
- 8.3 Neurogenetic Testing Typical Downstream Customers
- 8.4 Neurogenetic Testing Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
